What We're Reading: Page 2
Industry reads hand-picked by our editors
Jul 17, 2024
-
Fierce Pharma
Inside the FDA concerns that sank Hengrui’s PD-1 drug filing
-
Financial Times
The questions behind the Ozempic baby boom
-
The Wall Street Journal
Think You Will Live to 100? These Scientists Think You’re Wrong
Jul 16, 2024
Jul 15, 2024
-
The New York Times
Promised Cures, Tainted Cells: How Cord Blood Banks Mislead Parents
-
Reuters
Novo Nordisk faces scrutiny on Capitol Hill for pulling Levemir insulin from US market
-
Axios
Medicare proposes payment for digital mental health therapies
-
FirstWord Pharma
Legend jumps on takeout chatter amid Carvykti success
Jul 12, 2024
-
Nature Biotechnology News
CAR-Ts sweep into autoimmunity
-
Bloomberg Law
Slimmed-Down Drug Patent Crackdown Bill Progresses in Senate
-
ApexOnco
Roche declares KRAS war on Amgen and Bristol
-
Bloomberg
Health Care Is About to Get Even More Litigious